Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone

Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?

(2017) E. Palmerini et al.   EUROPEAN JOURNAL OF CANCER

Diaphyseal Femur Fractures in Osteogenesis Imperfecta: Characteristics and Relationship With Bisphosphonate Treatment

(2017) Pamela Trejo et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children With Osteogenesis Imperfecta

(2017) Ilkka Vuorimies et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy

(2017) Samantha Peiling Yang et al.   ONCOLOGIST

Denosumab: an Emerging Therapy in Pediatric Bone Disorders

(2017) Alison M. Boyce   Current Osteoporosis Reports

High frequency of osteonecrosis of the jaw among denosumab-treated prostate cancer patients

(2016) Leena Vehmanen et al.   ACTA ONCOLOGICA

A Subtrochanteric Femoral Stress Fracture following Bisphosphonate Treatment in an Adolescent Girl

(2016) Alison M. Boyce et al.   Hormone Research in Paediatrics

Recurrent Proximal Femur Fractures in a Teenager With Osteogenesis Imperfecta on Continuous Bisphosphonate Therapy: Are We Overtreating?

(2016) Rashida F Vasanwala et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Use of new targeted cancer therapies in children: effects on dental development and risk of jaw osteonecrosis: a review

(2016) Magali Hernandez et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Hypercalcemia after discontinuation of long-term denosumab treatment

(2016) A. S. Koldkjær Sølling et al.   OSTEOPOROSIS INTERNATIONAL

Severe hypercalcemia following denosumab treatment in a juvenile patient

(2015) Nokitaka Setsu et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Osteosclerosis induced by denosumab

(2015) Eisuke Kobayashi et al.   LANCET

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

(2015) Nathan Gossai et al.   PEDIATRIC BLOOD & CANCER

The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic review

(2014) Winnie Sohn et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

(2014) Salvatore L. Ruggiero et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

(2013) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of RANK-Ligand Antibody (Denosumab) Treatment on Bone Turnover Markers in a Girl With Juvenile Paget's Disease

(2013) Corinna Grasemann et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

(2013) Sant Chawla et al.   LANCET ONCOLOGY

Bisphosphonate-Related Femoral Periosteal Stress Reactions: Scoring System Based on Radiographic and MRI Findings

(2012) Meng Ai Png et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Denosumab Dose Selection for Patients with Bone Metastases from Solid Tumors

(2012) S. Doshi et al.   CLINICAL CANCER RESEARCH

Denosumab treatment for fibrous dysplasia

(2012) Alison M Boyce et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone mineral accrual from 8 to 30 years of age: An estimation of peak bone mass

(2011) Adam DG Baxter-Jones et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

(2011) Karim Fizazi et al.   LANCET

Femoral Cortical Stress Lesions in Long-Term Bisphosphonate Therapy: A Herald of Impending Fracture?

(2010) Joyce S B Koh et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

(2010) David Thomas et al.   LANCET ONCOLOGY

Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?

(2008) J. J. Brown et al.   CLINICAL ENDOCRINOLOGY

An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?

(2008) Ernest Beng Kee Kwek et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Tooth Extraction Socket Healing in Pediatric Patients Treated with Intravenous Pamidronate

(2008) Carol Chahine et al.   JOURNAL OF PEDIATRICS